Clinical Trial Update: Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the combination of Nab-Sirolimus with Letrozole for advanced or recurrent endometrioid endometrial cancer. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrioid Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)
• nab-sirolimus (sirolimus (nanoparticle albumin-bound formulation))

Snippet

Sponsor: Aadi Bioscience, Inc. | Conditions: Endometrial Cancer, Endometrioid Tumor | Phase 2 | Status: RECRUITING